Weatherden

Patients

A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.

News

A drug at the heart of Johnson & Johnson's $3bn takeover of Halda has been shown to be "highly active" in a first-in-human prostate cancer trial.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.